Mylan Introduces More Affordable EpiPen
Washington, D.C. — Attempting to recover from the well deserved backlash against evidence of up-charging the life saving medication, Mylan, the makers EpiPen, appears to have listened to consumers and have introduced an “affordable” option. “Look, we screwed up. We didn’t think people would catch on to our bullshit—for that we are sorry,” said Chief of Operations, Hannah […]